223 related articles for article (PubMed ID: 34327825)
1. Characteristics and outcomes of patients on concurrent direct oral anticoagulants and targeted anticancer therapies-TacDOAC registry: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy.
Wang TF; Baumann Kreuziger L; Leader A; Spectre G; Lim MY; Gahagan A; Gangaraju R; Sanfilippo KM; Mallick R; Zwicker JI; Carrier M
J Thromb Haemost; 2021 Aug; 19(8):2068-2081. PubMed ID: 34327825
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of relevant drug-drug interactions and associated clinical outcomes in patients with cancer-associated thrombosis on concurrent anticoagulation and anticancer or supportive care therapies.
Wang TF; Hill M; Mallick R; Chaudry H; Unachukwu U; Delluc A; Carrier M
Thromb Res; 2023 Nov; 231():128-134. PubMed ID: 37857226
[TBL] [Abstract][Full Text] [Related]
4. Direct oral anticoagulants in patients with hematologic malignancies.
Serrao A; Fiori L; Santoro C; De Luca ML; Ferretti A; De Luca G; Ligia S; Lapietra G; Mohamed S; Breccia M; Chistolini A
Hematol Oncol; 2020 Oct; 38(4):589-596. PubMed ID: 32588912
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease.
Shaw J; de Wit C; Le Gal G; Carrier M
J Thromb Haemost; 2017 May; 15(5):925-930. PubMed ID: 28296069
[TBL] [Abstract][Full Text] [Related]
6. Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: Updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation.
Martin KA; Beyer-Westendorf J; Davidson BL; Huisman MV; Sandset PM; Moll S
J Thromb Haemost; 2021 Aug; 19(8):1874-1882. PubMed ID: 34259389
[TBL] [Abstract][Full Text] [Related]
7. Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis.
Elsebaie MAT; van Es N; Langston A; Büller HR; Gaddh M
J Thromb Haemost; 2019 Apr; 17(4):645-656. PubMed ID: 30690830
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness and Safety of Direct-acting Oral Anticoagulants and Warfarin in Patients with Venous Thromboembolism and Active Cancer: An Observational Analysis.
Dawwas GK; Dietrich E; Smith SM; Davis K; Park H
Clin Ther; 2020 Sep; 42(9):e161-e176. PubMed ID: 32768247
[TBL] [Abstract][Full Text] [Related]
9. Safety of direct oral anticoagulants in patients with mild to moderate cirrhosis: a systematic review and meta-analysis.
Nisly SA; Mihm AE; Gillette C; Davis KA; Tillett J
J Thromb Thrombolysis; 2021 Oct; 52(3):817-827. PubMed ID: 33728575
[TBL] [Abstract][Full Text] [Related]
10. Reduced-dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta-analysis.
Vasanthamohan L; Boonyawat K; Chai-Adisaksopha C; Crowther M
J Thromb Haemost; 2018 Jul; 16(7):1288-1295. PubMed ID: 29772108
[TBL] [Abstract][Full Text] [Related]
11. Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta-analysis.
Valeriani E; Porreca E; Weitz JI; Schulman S; Candeloro M; Di Nisio M
J Thromb Haemost; 2020 Jul; 18(7):1661-1671. PubMed ID: 32202042
[TBL] [Abstract][Full Text] [Related]
12. Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors.
Carney BJ; Uhlmann EJ; Puligandla M; Mantia C; Weber GM; Neuberg DS; Zwicker JI
J Thromb Haemost; 2019 Jan; 17(1):72-76. PubMed ID: 30450803
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of direct oral anticoagulants vs. low molecular weight heparin for cancer-related venous thromboembolism: a meta-analysis of randomized trials.
Elbadawi A; Shnoda M; Mahmoud K; Elgendy IY
Eur Heart J Cardiovasc Pharmacother; 2021 Sep; 7(5):380-388. PubMed ID: 32556105
[TBL] [Abstract][Full Text] [Related]
14. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
Robertson L; Yeoh SE; Ramli A
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
[TBL] [Abstract][Full Text] [Related]
15. Direct oral anticoagulants in patients with venous thromboembolism and hematological malignancies.
Robinson R; Spectre G; Lishner M; Sharabi O; Robinson E; Hamburger Avnery O; Gafter-Gvili A; Raanani P; Leader A
J Thromb Thrombolysis; 2023 May; 55(4):729-736. PubMed ID: 36943661
[TBL] [Abstract][Full Text] [Related]
16. Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: A prospective cohort study.
Vedovati MC; Mancuso A; Pierpaoli L; Paliani U; Conti S; Ascani A; Galeotti G; Di Filippo F; Caponi C; Agnelli G; Becattini C
Int J Cardiol; 2020 Feb; 301():167-172. PubMed ID: 31761402
[TBL] [Abstract][Full Text] [Related]
17. Very elderly patients with venous thromboembolism on oral anticoagulation with VKAs or DOACs: Results from the prospective multicenter START2-Register Study.
Poli D; Antonucci E; Bertù L; Vignini E; Ruocco L; Mastroiacovo D; Paparo C; Pastori D; Testa S; Ageno W; Palareti G;
Thromb Res; 2019 Nov; 183():28-32. PubMed ID: 31536872
[TBL] [Abstract][Full Text] [Related]
18. Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register.
Palareti G; Antonucci E; Legnani C; Mastroiacovo D; Poli D; Prandoni P; Tosetto A; Pengo V; Testa S; Ageno W;
BMJ Open; 2020 Nov; 10(11):e040449. PubMed ID: 33247017
[TBL] [Abstract][Full Text] [Related]
19. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review.
Wu C; Alotaibi GS; Alsaleh K; Sean McMurtry M
Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174
[TBL] [Abstract][Full Text] [Related]
20. Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation.
Candeloro M; van Es N; Cantor N; Schulman S; Carrier M; Ageno W; Aibar J; Donadini MP; Bavalia R; Arsenault MP; Coppens M; Ferrante N; D'Addezio A; Sormani S; Porreca E; Di Nisio M
J Thromb Haemost; 2021 Oct; 19(10):2618-2628. PubMed ID: 34318606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
